Yarrow Bioscience, Inc.
YARW· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 |
|---|---|---|
| Revenue | $449.00K | — |
| Net Income | -$5.47M | -$2.27M |
| EPS Diluted | -$1.08 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yarrow Bioscience, Inc. · CIK 1566044 · Engraved from SEC EDGAR